Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol

NCT03155620 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT03155620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03155620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 31, 2017
Completion date
January 6, 2027
Enrollment
1,377 (actual)
Sites
172

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignant solid neoplasm, ann arbor stage iii non-hodgkin lymphoma, ann arbor stage iv non-hodgkin lymphoma, histiocytic sarcoma, juvenile xanthogranuloma, langerhans cell histiocytosis, malignant glioma, recurrent childhood rhabdomyosarcoma, recurrent ependymoma, recurrent ewing sarcoma, recurrent glioma, recurrent hepatoblastoma, recurrent langerhans cell histiocytosis, recurrent malignant germ cell tumor, recurrent malignant solid neoplasm, recurrent medulloblastoma, recurrent neuroblastoma, recurrent non-hodgkin lymphoma, recurrent osteosarcoma, recurrent peripheral primitive neuroectodermal tumor, recurrent primary central nervous system neoplasm, recurrent rhabdoid tumor, recurrent soft tissue sarcoma, refractory ewing sarcoma, refractory glioma, refractory hepatoblastoma, refractory langerhans cell histiocytosis, refractory malignant germ cell tumor, refractory malignant solid neoplasm, refractory medulloblastoma, refractory neuroblastoma, refractory non-hodgkin lymphoma, refractory osteosarcoma, refractory peripheral primitive neuroectodermal tumor, refractory primary central nervous system neoplasm, refractory rhabdoid tumor, refractory rhabdomyosarcoma, rhabdoid tumor, stage iii osteosarcoma ajcc v7, stage iii soft tissue sarcoma ajcc v7, stage iv osteosarcoma ajcc v7, stage iv soft tissue sarcoma ajcc v7, stage iva osteosarcoma ajcc v7, stage ivb osteosarcoma ajcc v7, wilms tumor